Details of the Drug

General Information of Drug (ID: DMB2I83)

Drug Name
SHP621
Indication
Disease Entry ICD 11 Status REF
Eosinophilic esophagitis DA24.1 Phase 2 [1]
Cross-matching ID
TTD ID
D06DLN

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)